NASDAQ:BIOL BIOLASE (BIOL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About BIOLASE Stock (NASDAQ:BIOL) Get BIOLASE alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3 shsAverage Volume2.58 million shsMarket Capitalization$581 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BIOLASE, Inc. was a medical device company focused on laser technology for dentistry. Its products were designed to support minimally invasive dental procedures involving both hard and soft tissue, with the goal of improving patient comfort, treatment efficiency and clinical outcomes. The company’s product portfolio included the Waterlase system, which used laser energy and a water spray for a range of dental procedures, and the Epic line of diode lasers for soft-tissue treatments, hygiene applications and related procedures. BIOLASE also offered accessories, disposable supplies, training and other support services for dental professionals. Founded in 1984, BIOLASE served dentists, dental specialists and hygienists in the United States and international markets through direct sales and distribution channels. The company was headquartered in Lake Forest, California. BIOLASE filed for Chapter 11 bankruptcy protection in 2023, and its subsequent corporate and operating status changed materially; therefore, historical descriptions of the company should be distinguished from the status of its former Nasdaq-listed securities.AI Generated. May Contain Errors. Read More Receive BIOL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOL Stock News HeadlinesBIOLASE (NASDAQ:BIOL) Shares Break Above 200-Day Moving Average - What's Next?October 17, 2026 | americanbankingnews.comBIOLASE and MegaGen America Expand Waterlase Foundations Training to Three U.S. Education CentersAugust 20, 2026 | tmcnet.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 23 at 1:00 AM | Banyan Hill Publishing (Ad)BIOLASE and MegaGen America Launch U.S. Commercial Collaboration to Advance "More Brilliant Dentistry Together"July 22, 2026 | finance.yahoo.comMegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California FacilityJune 25, 2026 | prnewswire.comBIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025November 25, 2025 | finance.yahoo.comBIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025October 14, 2025 | prnewswire.comBIOLASE MG LLC: BIOLASE Emerges Stronger Than Ever Under New Ownership by MegaGen ImplantSeptember 10, 2025 | finanznachrichten.deSee More Headlines BIOL Stock Analysis - Frequently Asked Questions How were BIOLASE's earnings last quarter? BIOLASE, Inc. (NASDAQ:BIOL) announced its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter. BIOLASE had a negative trailing twelve-month return on equity of 1,782.73% and a negative net margin of 41.65%. When did BIOLASE's stock split? BIOLASE shares reverse split on Friday, July 28th 2023.The 1-100 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of BIOLASE own? Based on aggregate information from My MarketBeat watchlists, some other companies that BIOLASE investors own include Zomedica (ZOM), Bionano Genomics (BNGO), Tonix Pharmaceuticals (TNXP), SNDL (SNDL), NIO (NIO), Ocugen (OCGN) and Senseonics Holdings, Inc. Common Stock (SENS). Company Calendar Last Earnings11/10/2021Today10/23/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:BIOL Previous SymbolNASDAQ:BLTI CIK811240 Webwww.biolase.com Phone(949) 361-1200Fax949-273-6677Employees160Year Founded1987Profitability EPS (Trailing Twelve Months)($14.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$20.63 million Net Margins-41.65% Pretax Margin-41.56% Return on Equity-1,782.73% Return on Assets-55.31% Debt Debt-to-Equity RatioN/A Current Ratio0.71 Quick Ratio0.36 Sales & Book Value Annual Sales$48.83 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / BookN/AMiscellaneous Outstanding Shares33,407,000Free Float33,317,000Market Cap$581 thousand OptionableNot Optionable Beta0.67 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:BIOL) was last updated on 10/22/2026 by MarketBeat.com Staff. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
